🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study researchers want to study the potential skin reaction after r...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-10
Trial ID
NCT04531813
Treatments Being Tested
This is an open-label, single-arm, randomized, evaluator-blinded repeat ins...
Status
Completed
Location
KGL Skin Study Center
Start Date
2021-04-12
Trial ID
NCT04882631
The aim of this exploratory study is to assess the ability of two test toot...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-11-09
Trial ID
NCT02856880
This is a single center, randomized, controlled, within subject comparison,...
Status
Completed
Location
Research Site
Start Date
2017-09-11
Trial ID
NCT03502434
Treatments Being Tested
The purpose of this study is to determine the skin irritation potential of ...
Status
Completed
Location
BioScience Laboratories, Inc.
Start Date
2014-07
Trial ID
NCT02198963
The purpose of the study is to determine whether Diltiazem Hydrochloride 2%...
Status
Unknown
Location
TKL Research
Start Date
2013-03
Trial ID
NCT01821274
This is a 7 day primary irritation patch test. This study investigates the ...
Status
Completed
Location
Multiple Locations
Start Date
2020-07-06
Trial ID
NCT06119750
Treatments Being Tested
This study is an evaluation of the irritation potential of 9 test products ...
Status
Unknown
Location
Bioscience Laboratories, Inc
Start Date
2021-06
Trial ID
NCT04942496
Treatments Being Tested
The goal of this observational study is to explore how the shape of the foo...
Status
Completed
Location
Fizyoterapi ve Rehabilitasyon Uygulama ve Araştırma Merkezi (İSÜFİZYOTEM).
Start Date
2025-07-02
Trial ID
NCT07764393
Researchers are looking for a better way to treat muscle and joint pains. R...
Status
Completed
Location
TKL Research, Inc.
Start Date
2024-07-23
Trial ID
NCT06511973
Treatments Being Tested